Neuraxis (NRXS) CEO Brian Carrico Receives RSU Award Worth $1.21M

What Happened

• Brian Carrico, CEO of Neuraxis, Inc. (NRXS), was granted 193,329 restricted stock units (RSUs) on 2026-08-13. The grant is reported as a derivative award valued at $1,214,106 using a per-share value of $6.28.
• This was an award (transaction code A), not an open-market purchase or sale. RSUs are compensation that convert to common shares only as they vest, so this is not an immediate share purchase or sale.

Key Details

• Transaction date: 2026-08-13; Form 4 filed: 2026-08-17 (filed within the standard two-business-day window).
• Grant size and value: 193,329 RSUs at $6.28 per share; total reported value $1,214,106.
• Vesting: RSUs vest in three equal annual installments over a three-year period (per footnote).
• Shares owned after transaction: not specified in the provided filing details.
• Transaction type: A (award/grant); recorded as derivative (RSUs), not an immediate issuance of common shares.

Context

• RSU grants are a form of executive compensation and typically indicate long-term incentive alignment rather than a direct market buy or sell. Because the units vest over time, they do not immediately change the CEO’s liquid holdings.
• For retail investors, grants are informative about compensation and expected retention incentives but do not by themselves indicate a near-term insider view on the stock price.